Antiphospholipid antibodies (aPL) are associated with thrombosis and pregnancy loss in
patients with systemic lupus erythematosus and antiphospholipid syndrome. Strong …

The antiphospholipid antibody syndrome (APS) is characterized by recurrent arterial and
venous thrombosis and/or pregnancy in association with antiphospholipid (aPL) antibodies …

The antiphospholipid syndrome (APS) is an autoimmune disease in which recurrent
vascular thrombosis, pregnancy morbidity or a combination of these events is associated …

Antiphospholipid (aPL) antibodies (Abs) are associated with thrombosis and pregnancy loss
in antiphospholipid syndrome (APS), a disorder initially characterised in patients with …

Pathogenic antiphospholipid antibodies (aPL) are the driving factors of recurrent pregnancy
loss and thrombosis that characterize antiphospholipid syndrome (APS). Current evidence …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by an
elevated risk for arterial and venous thrombosis and pregnancy-related morbidity. Since the …

Antiphospholipid antibodies (aPL) are associated with the recurrent pregnancy loss and
thrombosis that characterizes the antiphospholipid antibody syndrome (APS). Although the …

Antiphospholipid syndrome (APS) is a clinical autoimmune disorder characterised by
thrombosis, venous or arterial, and recurrent pregnancy morbidity in association with the …

Antiphospholipid syndrome (APS) is an acquired autoimmune disease characterized by
thromboembolic events, pregnancy morbidity, and the presence of antiphospholipid (aPL) …

Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis,
the pathogenic role of aPL in the development of thrombosis has not been fully elucidated …